期刊文献+

肺特异性X蛋白转染表达对A549肺癌株生物学功能的影响 被引量:1

Anti - proliferation and inducing apoptosis effects of lung - specific X protein on A549 lung cancer cell lines
原文传递
导出
摘要 目的观察肺特异性x蛋白(LUNX)转染表达对A549肺癌细胞株的增殖凋亡和生物学功能的影响。方法应用慢病毒基因转染表达方法检测LUNX表达对A549肺癌细胞株的抗增殖作用和生物学功能的影响;通过免疫组织化学法和实时定量聚合酶链反应(Real-timePCR)技术检测LUNX一小干扰RNA(siRNA)在A549肺癌株中的表达水平,Real—timePCR测定转染后A549肺癌细胞中增殖指标溴化脱氧尿嘧啶核苷(BrdUrd),碱性磷酸酶(AKP)和活性标志物表面活性蛋白C(SPC)的mRNA水平表达变化,并通过显微镜、苏木素.伊红(HE)染色、透射电镜等观察凋亡细胞的形态学改变。结果Real-timePCR和免疫细胞化学证实转染后A549肺癌细胞中有LUNX稳定表达;Real.timePCR结果示:A组AKP、SPC和BrdUrd密度为(0.73±0.14)、(0.53±0.12)、(O.31±0.10)U/L,B组为(1.64±0.38)、(1.47±0.25)、(1.28±0.21)U/L,C组为(1.71±0.45)、(1.53±0.32)、(1.33±0.26)U/L。与B、C对照组比较,A组AKP、SPC和BrdUrd扩增产物条带吸光度(A)值均显著降低(P〈0.01)。噻唑蓝(MTr)比色法表明:随着LUNX—siRNA与A549肺癌细胞效靶比增加及作用时间延长,抑制率明显增强(P〈0.05)。相同作用时间不同比例之间差异也均有统计学意义(P〈0.05),同一比例不同作用时间之间差异有统计学意义(P〈0.01)。LUNX-siRNA作用于肺癌细胞48h后,形态学观察肺癌细胞发生凋亡或坏死,与对照组比较,差异有统计学意义(P〈0.05)。结论体外制备的LUNX—siRNA对肺癌A549细胞具有抑制增殖和促进凋亡作用,其可能是通过通过负性调控信号通路降低A549肺癌细胞株中AKP、SPC和BrdUrd的表达。 Objective To study the anti - proliferation and inducing apoptosis effects of lung - specific X protein (LUNX) on A549 lung cancer cell lines. Methods The anti - proliferation and the cyto- toxicity of LUNX on A549 lung cancer cell line were detected by methyl thiazol tetrazolium (MTY) assay. To observe LUNX expression in A549 lung cancer cell lines, and the mRNA level were evaluated with real - time quantitative polymerase chain reaction (Real- time PCR). The morphological changes of the apeptosis cell were observed by invert microscope, hematoxylin and eosin (HE) stain, transmission electron micro- scope and acridine orange / ethidium bromide (AO/EB) double fluorescent staining. To analyze by using SPSS 14. 0 statistical software. Results The LUNX expression in Asg9 cells transfected with LUNX - small interfering RNA (siRNA) was confirmed by Real -time PCR and immunocytochemical method, respectively. Alkaline phosphatase (AKP), surfactant protein C (SPC) and bromodeoxyuridine (BrdUrd) in group A were (0.73 ±0. 14), (0.53 ±0. 12) and (0.31 ±0. 10) U/L, in group B were (1.64 ±0.38), (1.47 ± 0. 25) and ( 1.28 ±0. 21) U/L, in group C were (1.71±0. 45), (1.53 ±0. 32) and ( 1.33±0. 26) U/L. Compared with that in the control group, AKP, SPC and BrdUrd mRNA level decreased significantly in PEFLUNX transfected A549 cells (P 〈 0. 05 ). MTT assay showed that the inhibitory rate enhanced obvi- ously with the addition of effect/target rate and extension of time ( P 〈 0. 05 ). Lung cancer cell apoptosis or necrosis were morphologically observed after lung cancer cells were induced by LUNX for 48 hours ( P 〈 0. 05 ). Conclusion LUNX are highly effective protein which have a stronger anti - proliferation and inducing apoptosis effects on lung cancer ceils. LUNX protein might inhibit the proliferation of A549 cells by decreasing the expression of AKP, SPC and BrdUrd regulate pathway negatively.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第8期1783-1786,共4页 Chinese Journal of Experimental Surgery
关键词 肺癌 肺特异性X蛋白 A549细胞株 增殖 凋亡 Lung neoplasms Lung - specific X protein A549 cell lines Anti - proliferation Apoptosis
  • 相关文献

参考文献19

  • 1Lombardi D,Laeombe ML,Paggi MG.nm23:unraveling its biological function in cell differentiation[J].J Cell Physiol,2010,182 (2):144-149.
  • 2Sugi K,Kobayashi S,Yagi R,et al.Usefulness of sentinel lymph node biopsy for the detection of lymph node micrometastasis in early lung caneer[J].Inieract CardiovascThorac Surg,2008,7 (5):913-915.
  • 3Li SH,Wang Z,LiuXY,et al.Gene diagnosis and prognostic signifieance of lymph node micrometastasis after complete resection of histologically node-negative non-small cell lung cancer[J].World J Surg,2008,32(8):1652-2656.
  • 4杨帆,陈克终,隋锡朝,李剑锋,王俊,姜冠潮.K-Ras突变对表皮生长因子受体抑制剂敏感细胞株的影响[J].中华实验外科杂志,2010(1):96-97. 被引量:8
  • 5Nosotti M,Falleni M,Pallesehi A,et al.Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using careinoembryonic antigen marker[J].Chest,2005,128 (3):1539-1544.
  • 6AyabeT,Tomita M,Matsuzaki Y,et al.Micrometastasis and expression of nm23 messenger RNA of lymph nodes from lung cancer and the post operative clinieal outeome[J].Ann Thorae Cardiovase Surg,2007,10(3):152-159.
  • 7姜冠潮,杨帆,弱足力,黄宇清,王俊.非小细胞肺癌中表皮生长因子受体基因拷贝的检测及其临床意义[J].中华实验外科杂志,2008,25(7):905-906. 被引量:4
  • 8Mitas M,Cole DJ,Hoover L,et al.Real-time reverse transeriptionPCR detects KSI/4m RNA in mediastinal lymph nodes from patients with non-small cell Lung cancer[J].Clin Chem,2003,49 (2):312-315.
  • 9Bremnes RM,Veve R,Gabrielson E,et al.High throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small cell lung caneer[J].J Clin Oneol,2008,20(10):2417-2428.
  • 10Shibanuma H,Hirano T,Tsuji K,et al.Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung caneer[J].Lung Cancer,2008,22(2):85-95.

二级参考文献33

  • 1杨浩贤,吴一龙,陈刚,林嘉颖,杨学宁,王坤,谷力加.RT-PCR法检测外周血LUNX-mRNA诊断非小细胞肺癌微转移的研究[J].肿瘤防治研究,2004,31(8):464-466. 被引量:6
  • 2熊慧华,于世英,庄亮,熊华,龚建平.Survivin在紫杉醇介导MCF-7细胞凋亡中的作用[J].中华实验外科杂志,2006,23(6):718-720. 被引量:10
  • 3高尚志.我国心胸外科实验研究目前的热点和问题[J].中华实验外科杂志,2006,23(9):1031-1032. 被引量:3
  • 4王小林,侯建全,温端改,何军,岑建农,谷敏.利用RNA干扰阻抑膀胱癌细胞Survivin基因表达和诱导凋亡[J].中华实验外科杂志,2006,23(10):1174-1176. 被引量:12
  • 5Bunn PA, Dziadziuszko R, Varella-Garcia M, et al. Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy. Clin Cancer Res, 2006,12:3652-3656.
  • 6Cappuzzo F, Hirsch FR, Rossi E, et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst,2005 ,97 :643-655.
  • 7Tsao MS,Sakurada A,Cutz JC,et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med,2005 ,353 :133-144.
  • 8Dziadziuszko R, Witta SE, Cappuzzo F, et al. Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer. Clin Cancer Res,2006,12:3078- 3084.
  • 9Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med, 2002,2 : 92 -98.
  • 10Jaattela M. Escaping cell death: survival proteins in cancer. Exp Cell Res, 1999,248:30-43.

共引文献28

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部